|Invuity Inc -- USA Stock|| |
USD 3.85 0.30 7.23%
Vice President - Sales and Marketing
Mr. Robert Gerberich is a Vice President Sales and Marketing of the Company. since October 2012. From April 2012 to October 2012 Mr. Gerberich served as Senior Vice President of Global Sales and Field Development at Primcogent Solutions a noninvasive lowlevel laser therapy company. From January 2006 to April 2012 Mr. Gerberich served as President of UltraShape North America. Prior to UltraShape Mr. Gerberich served as the Vice President of Marketing and Sales and Vice President of Sales at Thermage Inc. a medical device company
Age: 47 President Since 2012
Gerberich received a B.S. in marketing from Illinois State University.
The company has return on total asset (ROA)
of (39.01) %
which means that it has lost $39.01 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (172.71) %
meaning that it created substantial loss on money invested by shareholders.
The company currently holds 34.62 M in liabilities with Debt to Equity (D/E) ratio of 641.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Invuity Inc has Current Ratio of 2.84 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Invuity, Inc., a medical technology company, develops various surgical devices to address various surgical procedures in the United States. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California. Invuity operates under Medical Instruments Supplies classification in USA and traded on NASDAQ General Markets exchange. It employs 172 people.Invuity Inc (IVTY) is traded on NASDAQ General Markets in USA. It is located in CALIFORNIA, U.S.A and employs 172 people. Invuity is listed under Medical Equipment category by Fama And French industry classification.